MTHFR and acute myeloid leukemia: Overall, the estimate results indicated non-significant increased risk association of MTHFR A1298C polymorphism with AML risk in some genetic models (OR, 1.11–1.13), without zero heterogeneity (P for heterogeneity, 0.562–0.955).